PetVivo Holdings, Inc.
PetVivo Holdings, Inc.
Your view on PETV
Overview
What the company does, where it operates, and who runs it.
About PetVivo Holdings, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John Lai
- Headquarters
- 5251 Edina Industrial Boulevard, Minneapolis, MN, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- John Lai
- Headquarters
- 5251 Edina Industrial Boulevard, Minneapolis, MN, US
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals.
Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for PetVivo Holdings, Inc., and the rating behind it. PETV last traded at $0.74; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for PetVivo Holdings, Inc.. Starting points for PetVivo Holdings, Inc.: EPS -$0.26, beta 1.16 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for PetVivo Holdings, Inc.. PetVivo Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for PetVivo Holdings, Inc.. Trailing twelve-month EPS for PetVivo Holdings, Inc. stands at -$0.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for PetVivo Holdings, Inc.. PetVivo Holdings, Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
PetVivo Holdings, Inc. valued side by side against its closest peers. PetVivo Holdings, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold PetVivo Holdings, Inc., and how their positions are changing. At a $20.1M market value, institutional positions materially move PetVivo Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by PetVivo Holdings, Inc. executives and directors. Shares of PetVivo Holdings, Inc. have traded between $0.45 and $1.69 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming PetVivo Holdings, Inc.. PetVivo Holdings, Inc. is a $20.1M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming PetVivo Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for PetVivo Holdings, Inc.. Coverage tracks PetVivo Holdings, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.